DEACAT vs mjn
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
DEACAT
Read full descriptionHide full description
Localitza en un mapa el desfibril·lador (DEA) més proper i truca als serveis d’emergència (112) per avisar d’una aturada cardiorespiratòria. Coneix els passos a seguir per a utilitzar el desfibril·lador. En aquest moment podràs localitzar els desfibril·ladors del programa Girona territori cardioprotegit www.gironaterritoricardioprotegit.cat. Tots els municipis de la demarcació de Girona disposen de, com a mínim, d’un desfibril·lador. Policia i Mossos d’Esquadra completen una xarxa de més de 700 desfibril·ladors. Amb aquest projecte els desfibril·ladors estan disponibles a tos els municipis des de la Costa Brava fins als Pirineus, per exemple: Girona, Figueres, Blanes, Lloret de Mar, Olot, Salt, Palafrugell, Sant Feliu de Guíxols, Roses, Banyoles, Palamós, Castelló d'Empúries, Santa Coloma de Farners, Ripoll, Calonge, Castell-Platja d'Aro, l'Escala, Puigcerdà, Tossa de Mar.
mjn
Read full descriptionHide full description
mjn-SERAS is a earpiece with an app that assesses the risk of epilepsy seizures. mjn-SERAS is a medical device that sends a warning signal when the risk of epilepsy seizure is high (the purchase of the product requires having the earpiece). mjn-SERAS records the electrical activity of the brain in real time and stores the information on specific servers. The artificial intelligence algorithm that permanently evaluates the risk of epilepsy seizures works in real time in the MJN-SERAS application of the user's mobile phone. mjn-SERAS is a medical device from mjn-neuro. mjn-SERAS is a CE marked medical device in accordance with European Regulation 2017/745 (MDR) and Royal Decree RD. 192/2023. Contraindications: Do not use the product in case of suffering from an infection in the ear canal or in case of suffering a skin lesion in the vicinity of the product's area of influence. Clinical studies using Real World Data show an accuracy of 99%, a sensitivity of 83% and a specificity of 99%.
Screenshots
Verdict
DEACAT and mjn are too close to call on the numbers: across 6 compared parameters — price, update cadence, ads and in-app purchases among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
DEACAT ships an update fortnightly, mjn monthly. The most recent releases landed on October 14, 2026 and October 24, 2026 respectively.
| Parameter | DEACAT | mjn |
|---|---|---|
| Price | Free | Free |
| Update frequency | Fortnightly — better | Monthly |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone | iPhone, iPod — better |
| Requires iOS | 16.6 | 15.6 — better |
| Further details — not scored | ||
| Size | 19 MB | 103 MB |
| Age rating | 12+ | 4+ |
| Developer | Dipsalut Organisme de Salut P�blica de la Diputaci� de Girona | mjn-neuro |
In-app purchases
DEACAT
No in-app purchases
mjn
No in-app purchases









